Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandros A Drosos

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Drugs|April 4, 2002
Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapyAlexandros A Drosos
Autoimmunity Reviews|April 13, 2005
Epidemiology of adult rheumatoid arthritisYannis Alamanos, Alexandros A Drosos
Joint Bone Spine|December 25, 2010
Management of Raynaud's phenomenon and digital ulcers in systemic sclerosisVasileios Botzoris, Alexandros A Drosos
Expert Opinion on Biological Therapy|June 9, 2011
Abatacept: a biologic immune modulator for rheumatoid arthritisCharalampos Papagoras, Alexandros A Drosos
Expert Opinion on Pharmacotherapy|March 22, 2022
State-of-the-art glucocorticoid-targeted drug therapies for the treatment of rheumatoid arthritisEleftherios Pelechas, Alexandros A Drosos
Expert Opinion on Biological Therapy|January 9, 2019
Etanercept biosimilar SB-4Eleftherios Pelechas, Alexandros A Drosos
Expert Opinion on Biological Therapy|March 5, 2014
Adalimumab in the treatment of rheumatoid arthritisParaskevi V Voulgari, Alexandros A Drosos
Mediterranean Journal of Rheumatology|May 8, 2026
Optimising Conventional Therapy in Rheumatoid ArthritisAlexandros A Drosos, Paraskevi V Voulgari
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
Onercept. SeronoSpyros N Nikas, Alexandros A Drosos
Expert Opinion on Biological Therapy|January 17, 2007
Adalimumab for rheumatoid arthritisParaskevi V Voulgari, Alexandros A Drosos
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Drugs|April 4, 2002
Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapyAlexandros A Drosos
Autoimmunity Reviews|April 13, 2005
Epidemiology of adult rheumatoid arthritisYannis Alamanos, Alexandros A Drosos
Joint Bone Spine|December 25, 2010
Management of Raynaud's phenomenon and digital ulcers in systemic sclerosisVasileios Botzoris, Alexandros A Drosos
Expert Opinion on Biological Therapy|June 9, 2011
Abatacept: a biologic immune modulator for rheumatoid arthritisCharalampos Papagoras, Alexandros A Drosos
Expert Opinion on Pharmacotherapy|March 22, 2022
State-of-the-art glucocorticoid-targeted drug therapies for the treatment of rheumatoid arthritisEleftherios Pelechas, Alexandros A Drosos
Expert Opinion on Biological Therapy|January 9, 2019
Etanercept biosimilar SB-4Eleftherios Pelechas, Alexandros A Drosos
Expert Opinion on Biological Therapy|March 5, 2014
Adalimumab in the treatment of rheumatoid arthritisParaskevi V Voulgari, Alexandros A Drosos
Mediterranean Journal of Rheumatology|May 8, 2026
Optimising Conventional Therapy in Rheumatoid ArthritisAlexandros A Drosos, Paraskevi V Voulgari
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
Onercept. SeronoSpyros N Nikas, Alexandros A Drosos
Expert Opinion on Biological Therapy|January 17, 2007
Adalimumab for rheumatoid arthritisParaskevi V Voulgari, Alexandros A Drosos
Pageof 17